| Year |
Title |
Altmetric |
| 2022
|
α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth.
JCI Insight.
7.
2022
|
|
| 2022
|
ST6Gal1: Oncogenic signaling pathways and targets.
Frontiers in Molecular Biosciences.
9.
2022
|
|
| 2022
|
The incorrect use of CD75 as a synonym for ST6GAL1 has fostered the expansion of commercial "ST6GAL1" antibodies that do not recognize ST6GAL1.
Glycobiology.
32:736-742.
2022
|
|
| 2022
|
Hypersialylation of Tumor Cells Promotes Pancreatic Cancer Progression
2022
|
|
| 2022
|
ST6Gal1 Contributes to Pancreatic Cancer Initiation by Promoting Pancreatitis-Induced Acinar to Ductal Metaplasia
2022
|
|
| 2022
|
The sialyltransferase ST6Gal1 is upregulated in a cytokine-mediated manner during pancreatitis
2022
|
|
| 2022
|
ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion.
Journal of Biological Chemistry.
298.
2022
|
|
| 2022
|
Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
Journal of Biological Chemistry.
298.
2022
|
|
| 2021
|
Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
Glycobiology.
31:530-539.
2021
|
|
| 2021
|
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells.
Journal of Biological Chemistry.
296.
2021
|
|
| 2020
|
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells..
Journal of Biological Chemistry.
296:100034.
2020
|
|
| 2020
|
Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase.
PLoS One.
15.
2020
|
|
| 2020
|
Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.
Journal of Biological Chemistry.
295:14153-14163.
2020
|
|
| 2019
|
Sustained delivery of the angiogenic QK peptide through the use of polyglutamate domains to control peptide release from bone graft materials.
Journal of Biomedical Materials Research Part A.
107:2764-2773.
2019
|
|
| 2019
|
3D printed mesh reinforcements enhance the mechanical properties of electrospun scaffolds.
Biomaterials Research.
23.
2019
|
|
| 2019
|
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Journal of Ovarian Research.
12.
2019
|
|
| 2019
|
Addition of an oligoglutamate domain to bone morphogenic protein 2 confers binding to hydroxyapatite materials and induces osteoblastic signaling.
PLoS One.
14.
2019
|
|
| 2019
|
Transfer of Functional Cargo in Exomeres.
Cell Reports.
27:940-954.e6.
2019
|
|
| 2019
|
The addition of a polyglutamate domain to the angiogenic QK peptide improves peptide coupling to bone graft materials leading to enhanced endothelial cell activation.
PLoS One.
14.
2019
|
|
| 2018
|
Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation.
Journal of Experimental Medicine.
215:1803-1812.
2018
|
|
| 2018
|
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 signaling.
Journal of Biological Chemistry.
293:5659-5667.
2018
|
|
| 2018
|
Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
Journal of Ovarian Research.
11.
2018
|
|
| 2018
|
ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Journal of Biological Chemistry.
293:1610-1622.
2018
|
|
| 2018
|
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
Journal of Biological Chemistry.
293:984-994.
2018
|
|
| 2017
|
Enhanced skin regeneration using a novel amniotic-derived tissue graft
2017
|
|
| 2017
|
The glycosyltransferase ST6Gal-I protects tumor cells against serum growth factor withdrawal by enhancing survival signaling and proliferative potential.
Journal of Biological Chemistry.
292:4663-4673.
2017
|
|
| 2016
|
The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype.
Cancer Research.
76:3978-3988.
2016
|
|
| 2016
|
Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds.
Matrix Biology.
52-54:397-412.
2016
|
|
| 2016
|
Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.
Clinical materials.
77:307-319.
2016
|
|
| 2015
|
Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials
2015
|
|
| 2015
|
Using inositol as a biocompatible ligand for efficient transgene expression.
International Journal of Nanomedicine.
10:2871-2884.
2015
|
|
| 2015
|
Microporous dermal-mimetic electrospun scaffolds pre-seeded with fibroblasts promote tissue regeneration in full-thickness skin wounds.
PLoS One.
10.
2015
|
|
| 2014
|
Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials.
International Journal of Oral and Maxillofacial Implants.
29:1437-1445.
2014
|
|
| 2014
|
Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration
2014
|
|
| 2014
|
Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains.
Journal of Biomedical Materials Research Part A.
102:1008-1016.
2014
|
|
| 2013
|
Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Clinical Cancer Research.
19:6484-6494.
2013
|
|
| 2013
|
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.
Journal of Ovarian Research.
6.
2013
|
|
| 2013
|
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
Cancer Research.
73:2368-2378.
2013
|
|
| 2013
|
Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.
Clinical materials.
34:2455-2462.
2013
|
|
| 2013
|
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.
Clinical materials.
34:1506-1513.
2013
|
|
| 2012
|
Regulation of the metastatic cell phenotype by sialylated glycans.
Cancer and Metastasis Reviews.
31:501-518.
2012
|
|
| 2012
|
Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds.
PLoS One.
7.
2012
|
|
| 2012
|
Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration.
Clinical materials.
33:524-534.
2012
|
|
| 2011
|
Nanocomposite scaffolds based on electrospun polycaprolactone/modified CNF/nanohydroxyapatite by electrophoretic deposition.
Journal of biomaterials and tissue engineering.
1:177-184.
2011
|
|
| 2011
|
ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
Journal of Biological Chemistry.
286:39654-39662.
2011
|
|
| 2011
|
Sialylation of the Fas death receptor by St6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.
Journal of Biological Chemistry.
286:22982-22990.
2011
|
|
| 2011
|
Advantages of RGD peptides for directing cell association with biomaterials.
Clinical materials.
32:4205-4210.
2011
|
|
| 2011
|
Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells.
Journal of Biomedical Materials Research Part A.
97 A:145-151.
2011
|
|
| 2011
|
Emerging role of α2,6-sialic acid as a negative regulator of galectin binding and function.
Journal of Biological Chemistry.
286:5935-5941.
2011
|
|
| 2011
|
Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite.
PLoS One.
6.
2011
|
|
| 2010
|
Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain.
Clinical materials.
31:9586-9594.
2010
|
|
| 2010
|
An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold.
Clinical materials.
31:4376-4381.
2010
|
|
| 2010
|
Aligned bioactive multi-component nanofibrous nanocomposite scaffolds for bone tissue engineering.
Macromolecular Bioscience.
10:433-444.
2010
|
|
| 2009
|
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix.
Biomacromolecules.
10:2935-2944.
2009
|
|
| 2009
|
The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces.
Clinical materials.
30:1898-1909.
2009
|
|
| 2008
|
Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite.
Journal of Materials Science: Materials in Medicine.
19:3567-3574.
2008
|
|
| 2008
|
Effect of altered glycosylation on the structure of the I-like domain of β1 integrin: A molecular dynamics study
2008
|
|
| 2008
|
Working group report: The roles of glycans in hemostasis, inflammation and vascular biology.
Glycobiology.
18:747-749.
2008
|
|
| 2008
|
ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function..
Journal of Ovarian Research.
1:3.
2008
|
|
| 2008
|
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
Experimental Cell Research.
314:2941-2950.
2008
|
|
| 2008
|
Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of α4β1 integrins.
Journal of Biological Chemistry.
283:26364-26373.
2008
|
|
| 2008
|
Sialylation of β1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis.
Journal of Biological Chemistry.
283:22177-22185.
2008
|
|
| 2008
|
Mesenchymal stem cell interaction with ultra-smooth nanostructured diamond for wear-resistant orthopaedic implants.
Clinical materials.
29:3461-3468.
2008
|
|
| 2008
|
The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials.
Clinical materials.
29:3075-3083.
2008
|
|
| 2008
|
Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
Biochemical and Biophysical Research Communications.
366:1025-1029.
2008
|
|
| 2007
|
Identification of a HoxA10 activation domain necessary for transcription of the gene encoding β3 integrin during myeloid differentiation.
Journal of Biological Chemistry.
282:16846-16859.
2007
|
|
| 2007
|
The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite.
Clinical materials.
28:383-392.
2007
|
|
| 2006
|
Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide.
Clinical materials.
27:2201-2212.
2006
|
|
| 2006
|
Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy.
Journal of Biomedical Materials Research Part A.
76:279-287.
2006
|
|
| 2005
|
The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion.
Clinical materials.
26:7046-7056.
2005
|
|
| 2005
|
A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering β1 integrin sialylation.
Journal of Biological Chemistry.
280:37610-37615.
2005
|
|
| 2005
|
Hypersialylation of β 1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
Cancer Research.
65:4645-4652.
2005
|
|
| 2005
|
Erratum: Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite (Journal of Biomedical Materials Research - Part A (2004) 68A, 2 (273-285) DOI: 10.1002/jbm.a.20043).
Journal of Biomedical Materials Research Part A.
73:254.
2005
|
|
| 2005
|
Regulation of mesenchymal stem cell attachment and spreading on hydroxyapatite by RGD peptides and adsorbed serum proteins.
Clinical materials.
26:1467-1475.
2005
|
|
| 2004
|
Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials.
Journal of Nanoscience and Nanotechnology.
4:986-989.
2004
|
|
| 2004
|
Variant glycosylation: An underappreciated regulatory mechanism for β1 integrins
2004
|
|
| 2004
|
Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite.
Journal of Biomedical Materials Research Part A.
68:273-285.
2004
|
|
| 2003
|
Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin.
Oncogene.
22:7137-7145.
2003
|
|
| 2002
|
Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors.
Journal of Biological Chemistry.
277:32830-32836.
2002
|
|
| 2001
|
TGF-β1 up-regulates paxillin protein expression in malignant astrocytoma cells: Requirement for a fibronectin substrate.
Oncogene.
20:7976-7986.
2001
|
|
| 2001
|
Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel.
Journal of Applied Biomaterials.
57:258-267.
2001
|
|
| 1999
|
Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras..
Journal of Cellular Physiology.
181:33-44.
1999
|
|
| 1999
|
Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) β1 in cells with nonfunctional TGF-β receptor type III.
Molecular Cancer Research.
10:11-18.
1999
|
|
| 1999
|
Steps in integrin β1-chain glycosylation mediated by TGFβ1 signaling through ras.
Journal of Cellular Physiology.
181:33-44.
1999
|
|
| 1997
|
Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin.
Biochemical Journal.
325:375-381.
1997
|
|
| 1995
|
Affinity purification of hydra glutathione bindings proteins. [FEBS Letters 354 (1994) 320-324] (PII:0014-5793(94)01154-0).
FEBS Letters.
362:98.
1995
|
|
| 1995
|
Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase.
Journal of Biological Chemistry.
270:17437-17441.
1995
|
|
| 1994
|
Signal transduction for taurocholic acid in the olfactory system of atlantic salmon.
Chemical Senses.
19:371-380.
1994
|
|
| 1994
|
Affinity purification of Hydra glutathione binding proteins.
FEBS Letters.
354:320-324.
1994
|
|
| 1992
|
Chemoreception in hydra: specific binding of glutathione to a membrane fraction
1992
|
|
| 1992
|
Partial Characterization and Detergent Solubilization of the Putative Glutathione Chemoreceptor from Hydra.
Biochemistry.
31:9838-9843.
1992
|
|
| 1991
|
Chemoreception in Hydra vulgaris (attenuata): initial characterization of two distinct binding sites for l-glutamic acid
1991
|
|
